Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pharmacokinetics and Safety of Mitragynine in Beagle Dogs
Elizabeth A. Maxwell, Tamara I. King, Shyam H. Kamble, et al.
Planta Medica (2020) Vol. 86, Iss. 17, pp. 1278-1285
Open Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

Therapeutic benefit with caveats?: Analyzing social media data to understand the complexities of kratom use
Kirsten E. Smith, Jeffrey M. Rogers, Destiny Schriefer, et al.
Drug and Alcohol Dependence (2021) Vol. 226, pp. 108879-108879
Open Access | Times Cited: 56
Clinical Pharmacokinetic Assessment of Kratom (Mitragyna speciosa), a Botanical Product with Opioid-like Effects, in Healthy Adult Participants
Rakshit S. Tanna, James Nguyen, Deena L. Hadi, et al.
Pharmaceutics (2022) Vol. 14, Iss. 3, pp. 620-620
Open Access | Times Cited: 42
Human Mitragynine and 7-Hydroxymitragynine Pharmacokinetics after Single and Multiple Daily Doses of Oral Encapsulated Dried Kratom Leaf Powder
Marilyn A. Huestis, Martin A. Brett, J. Bothmer, et al.
Molecules (2024) Vol. 29, Iss. 5, pp. 984-984
Open Access | Times Cited: 13
Exploring the Chemistry of Alkaloids from Malaysian Mitragyna speciosa (Kratom) and the Role of Oxindoles on Human Opioid Receptors
Nelson Jeng‐Yeou Chear, Francisco León, Abhisheak Sharma, et al.
Journal of Natural Products (2021) Vol. 84, Iss. 4, pp. 1034-1043
Open Access | Times Cited: 55
Metabolism of a Kratom Alkaloid Metabolite in Human Plasma Increases Its Opioid Potency and Efficacy
Shyam H. Kamble, Francisco León, Tamara I. King, et al.
ACS Pharmacology & Translational Science (2020) Vol. 3, Iss. 6, pp. 1063-1068
Open Access | Times Cited: 51
A Novel Mitragynine Analog with Low-Efficacy Mu Opioid Receptor Agonism Displays Antinociception with Attenuated Adverse Effects
Soumen Chakraborty, Jeffrey F. DiBerto, Abdelfattah Faouzi, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 18, pp. 13873-13892
Open Access | Times Cited: 50
Oxidative Metabolism as a Modulator of Kratom’s Biological Actions
Soumen Chakraborty, Rajendra Uprety, Samuel T. Slocum, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 22, pp. 16553-16572
Open Access | Times Cited: 43
Pharmacokinetics of Eleven Kratom Alkaloids Following an Oral Dose of Either Traditional or Commercial Kratom Products in Rats
Shyam H. Kamble, Erin C. Berthold, Tamara I. King, et al.
Journal of Natural Products (2021) Vol. 84, Iss. 4, pp. 1104-1112
Open Access | Times Cited: 36
Kratom Abuse Potential 2021: An Updated Eight Factor Analysis
Jack E. Henningfield, Daniel W. Wang, Marilyn A. Huestis
Frontiers in Pharmacology (2022) Vol. 12
Open Access | Times Cited: 26
In vitro and in vivo pharmacology of kratom
Takato Hiranita, Samuel Obeng, Abhisheak Sharma, et al.
Advances in pharmacology (2022), pp. 35-76
Closed Access | Times Cited: 23
A systematic review of (pre)clinical studies on the therapeutic potential and safety profile of kratom in humans
Elisabeth Prevete, Kim P. C. Kuypers, Eef L. Theunissen, et al.
Human Psychopharmacology Clinical and Experimental (2021) Vol. 37, Iss. 1
Open Access | Times Cited: 32
Translating Kratom-Drug Interactions: From Bedside to Bench and Back
Rakshit S. Tanna, Nadja B. Cech, Nicholas H. Oberlies, et al.
Drug Metabolism and Disposition (2023) Vol. 51, Iss. 8, pp. 923-935
Open Access | Times Cited: 12
Effects of kratom alkaloids on mesolimbic dopamine release
James P Manus, Rebecca C Crenshaw, Lindsay C Ringer, et al.
Neuroscience Letters (2025), pp. 138153-138153
Closed Access
In Vitro and In Vivo Pharmacokinetic Characterization of 7-Hydroxymitragynine, an Active Metabolite of Mitragynine, in Sprague-Dawley Rats
Yi‐Hua Chiang, Raju S. Kanumuri, Michelle A. Kuntz, et al.
European Journal of Drug Metabolism and Pharmacokinetics (2025)
Closed Access
Multiple-Dose Pharmacokinetics and Safety of Mitragynine, the Major Alkaloid of Kratom, in Rats
Yi‐Hua Chiang, Erin C. Berthold, Michelle A. Kuntz, et al.
ACS Pharmacology & Translational Science (2024) Vol. 7, Iss. 8, pp. 2452-2464
Closed Access | Times Cited: 3
The Mitragyna speciosa (kratom) alkaloid mitragynine: analysis of adrenergic α2 receptor activity in vitro and in vivo
Samuel Obeng, Morgan L. Crowley, Marco Mottinelli, et al.
European Journal of Pharmacology (2024) Vol. 980, pp. 176863-176863
Open Access | Times Cited: 3
The Lack of Contribution of 7-Hydroxymitragynine to the Antinociceptive Effects of Mitragynine in Mice: A Pharmacokinetic and Pharmacodynamic Study
Erin C. Berthold, Shyam H. Kamble, Raju S. Kanumuri, et al.
Drug Metabolism and Disposition (2021) Vol. 50, Iss. 2, pp. 158-167
Open Access | Times Cited: 18
Respiratory effects of oral mitragynine and oxycodone in a rodent model
Jack E. Henningfield, Joseph V. Rodricks, Aaron M. Magnuson, et al.
Psychopharmacology (2022) Vol. 239, Iss. 12, pp. 3793-3804
Open Access | Times Cited: 12
Pharmacokinetic and Pharmacodynamic Consequences of Cytochrome P450 3A Inhibition on Mitragynine Metabolism in Rats
Shyam H. Kamble, Samuel Obeng, Francisco León, et al.
Journal of Pharmacology and Experimental Therapeutics (2023) Vol. 385, Iss. 3, pp. 180-192
Open Access | Times Cited: 6
Preclinical pharmacokinetic studies of villocarine A, an active Uncaria alkaloid
Yi‐Hua Chiang, Nelson Jeng‐Yeou Chear, Erin C. Berthold, et al.
Drug Testing and Analysis (2024)
Closed Access | Times Cited: 1
Beneficial and Adverse Health Effects of Kratom (Mitragyna speciosa): A Critical Review of the Literature
J. Thomas Heywood, S. Smallets, Dennis J. Paustenbach
Food and Chemical Toxicology (2024) Vol. 192, pp. 114913-114913
Closed Access | Times Cited: 1
Oral Pharmacokinetics in Beagle Dogs of the Mitragynine Metabolite, 7-Hydroxymitragynine
Elizabeth A. Maxwell, Tamara I. King, Shyam H. Kamble, et al.
European Journal of Drug Metabolism and Pharmacokinetics (2021) Vol. 46, Iss. 3, pp. 459-463
Open Access | Times Cited: 9
Kratom: Substance of Abuse or Therapeutic Plant?
David A. Gorelick
Psychiatric Clinics of North America (2022) Vol. 45, Iss. 3, pp. 415-430
Closed Access | Times Cited: 6
Development and validation of a gradient HPLC-UV method for mitragynine following in vitro skin permeation studies
Yee Shan Sim, Zan Yang Chong, Juzaili Azizi, et al.
Journal of Chromatography B (2022) Vol. 1204, pp. 123316-123316
Closed Access | Times Cited: 5
Pharmacology and toxicology of kratom
Miroslav Pohanka
Bratislavské lekárske listy/Bratislava medical journal (2023) Vol. 124, Iss. 12, pp. 896-902
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top